AbbVie Inc. (ABBV) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-03 (expected, time not announced). EPS estimate 3.89, revenue estimate 18.35B.
Over the last 12 reports the stock moved 4.9% on average (either way), rising 7 times and falling 5. EPS beat estimates 11 of 12 times; revenue 12 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-30 | 3.82 | 3.73 | +2.4% | 17.40B | 17.32B | -0.6% |
| Q2 FY2026 | 2026-07-31 | 3.65 | 3.61 | +1.1% | 16.99B | 16.80B | -4.8% |
| Q1 FY2026 | 2026-04-29 | 2.65 | 2.59 | +2.3% | 15.00B | 14.72B | +6.9% |
| Q4 FY2025 | 2026-02-04 | 2.71 | 2.65 | +2.3% | 16.62B | 16.41B | -2.9% |
| Q3 FY2025 | 2025-10-31 | 1.86 | 1.77 | +5.1% | 15.78B | 15.59B | -7.1% |
| Q2 FY2025 | 2025-07-31 | 2.97 | 2.88 | +3.1% | 15.42B | 15.03B | +3.1% |
| Q1 FY2025 | 2025-04-25 | 2.46 | 2.38 | +3.4% | 13.34B | 12.93B | +6.6% |
| Q4 FY2024 | 2025-01-31 | 2.16 | 2.98 | -27.5% | 15.10B | 14.83B | +8.2% |